Syncom Formulations (India) Ltd Share Price
(SYNCOMF)
Check the latest share price of Syncom Formulations (India) Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 12:03PM, 13 May 2025
NSE
Syncom Formulations (India) Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹16.26Day's Price Range₹16.7252 Week's Low
52 Week's High
₹10.9552-Week Price Range₹27.9
| Returns % | |
| 1 Month Return | -5.52 % |
| 3 Month Return | -8.87 % |
| 1 Year Return | + 25.98 % |
| 3 Year Return | + 75.27 % |
| 5 Year Return | + 1648.94 % |
| Market Stats | |
| Previous Close | ₹16.44 |
| Open | ₹16.62 |
| Volume | 11.05L |
| Upper Circuit | ₹19.72 |
| Lower Circuit | ₹13.15 |
Syncom Formulations (India) Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹1,545.36 Cr
Return on Equity (ROE)
8.71
PE Ratio (TTM)
32.24
Return on capital employed (ROCE)
10.32
Industry PE ratio
53.64
Beta (LTM)
1.23
P/B Ratio
3.67
Dividend Yield
0PEG Ratio
189.62
Quarterly Earnings Growth YOY
85.71
EPS (TTM)
0.27
Sector
Pharmaceuticals
Book Value
3.07
Technical Analysis
Bearish
View Technical Analysis
How to invest in Syncom Formulations (India) Ltd
Investing in Syncom Formulations (India) Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Syncom Formulations (India) Ltd or SYNCOMF on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Syncom Formulations (India) Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Syncom Formulations (India) Ltd with just a few clicks!
Syncom Formulations (India) Ltd Stock's Interest Amongst Investors
Syncom Formulations (India) Ltd Valuation
Track how the P/E of Syncom Formulations (India) Ltd has moved over time to understand valuation trends.
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (32.24x)
May 12, 2025
Industry (53.64x)
May 12, 2025
Highest (81.74x)
January 18, 2022
Today’s Price to Earnings Ratio: 32.24x
Syncom Formulations (India) Ltd Financials
Get the annual and quarterly financial summary of Syncom Formulations (India) Ltd, including revenue, profit, loss and more.
Syncom Formulations (India) Ltd Index Inclusions
Syncom Formulations (India) Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Syncom Formulations (India) Ltd.
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit jumped 85.71% since last year same period to ₹13Cr in the Q3 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 17.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.18%.
Read More about Dividends
Syncom Formulations (India) Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syncom Formulations (India) Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.11% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.32% | 0.00 | |
| Others | 0% | 0.00 |
Syncom Formulations (India) Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Syncom Formulations (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,545.36 | 329.79% | 0.61 | 25 | 263 | |
| NA | 122.69 | 100.86% | 0.50 | 14 | 95 | |
| NA | 70.03 | 94.93% | 2.00 | 14 | 502 | |
| NA | 105.17 | 71.57% | 0.50 | 9 | 188 | |
| NA | 50.03 | 42.59% | 0.50 | 1 | 67 |
Syncom Formulations (India) Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Syncom Formulations (India) Ltd.
Syncom Formulations Reports Strong Q3FY25 Growth - 20 Apr, 2025
In Q3FY25, Syncom Formulations reported a 25% increase in revenue from Rs 101 crores to Rs 127 crores, while net profits rose 18% from Rs 11 crores to Rs 13 crores. The current share price is Rs 17.56, with a market capitalization of Rs 1,633.72 crores and yearly stock returns of 38.81%.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 49.30% to 49.32% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 61.71 Cr → 131.57 Cr (in ₹), with an average increase of 11.7% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 7 quarters, 4.4 Cr → 13.0 Cr (in ₹), with an average increase of 15.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, SYNCOMF stock has moved up by 5.7%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 51.9% return, outperforming this stock by 25.9%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.7% return, outperforming this stock by 75.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 0.13% to 0.11% in Mar 2025 quarter
About Syncom Formulations (India) Ltd
Revenue: ₹127.53Cr as on December 2024 (Q4 24)
Net Profit: ₹13.00Cr as on December 2024 (Q4 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| CEO | Kedarmal Bankda |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Syncom Formulations (India) Ltd
Check out the Mutual Funds with significant holdings in Syncom Formulations (India) Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.06% |
FAQs
What is Syncom Formulations (India) Ltd price today?
Syncom Formulations (India) Ltd share price today stands at ₹16.62, Open: ₹16.62, Previous Close: ₹16.44, High: ₹16.72, Low: ₹16.26, 52 Week High: ₹27.9, 52 Week Low: ₹10.95.
How to Buy Syncom Formulations (India) Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Syncom Formulations (India) Ltd shares
What are today's traded volumes of Syncom Formulations (India) Ltd?
Today's traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 11.05L.
What is today's market capitalisation of Syncom Formulations (India) Ltd?
Today's market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1,545.36 Cr.
What is the 52 Week High and Low Range of Syncom Formulations (India) Ltd?
How much percentage Syncom Formulations (India) Ltd is down from its 52 Week High?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹16.62. It is down -40.43% from its 52 Week High price of ₹27.9
How much percentage Syncom Formulations (India) Ltd is up from its 52 Week low?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹16.62. It is up 51.78% from its 52 Week Low price of ₹10.95